Rezultati pretrage - Helland, Thomas
- Prikaz rezultata 1 – 10 od 10
-
1
Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer od Helland, Thomas, Alsomairy, Sarah, Lin, Chenchia, Søiland, Håvard, Mellgren, Gunnar, Hertz, Daniel Louis
Izdano 2021Tekst -
2
Downregulation of Steroid Receptor Coactivator-2 Modulates Estrogen-Responsive Genes and Stimulates Proliferation of MCF-7 Breast Cancer Cells od Fenne, Ingvild S., Helland, Thomas, Flågeng, Marianne H., Dankel, Simon N., Mellgren, Gunnar, Sagen, Jørn V.
Izdano 2013Tekst -
3
Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites od Chen, Yuanhuang, Marcath, Lauren A., Eliassen, Finn Magnus, Lende, Tone Hoel, Soiland, Havard, Mellgren, Gunnar, Helland, Thomas, Hertz, Daniel Louis
Izdano 2021Tekst -
4
The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells od Helland, Thomas, Gjerde, Jennifer, Dankel, Simon, Fenne, Ingvild S., Skartveit, Linn, Drangevåg, Andreas, Bozickovic, Olivera, Flågeng, Marianne Hauglid, Søiland, Håvard, Mellgren, Gunnar, Lien, Ernst A.
Izdano 2015Tekst -
5
First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: a case study od Peccatori, Fedro Alessandro, Codacci-Pisanelli, Giovanni, Mellgren, Gunnar, Buonomo, Barbara, Baldassarre, Eleonora, Lien, Ernst Asbjorn, Bifulco, Ersilia, Hustad, Steinar, Zachariassen, Emil, Johansson, Harriet, Helland, Thomas
Izdano 2020Tekst -
6
Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients od Bertelsen, Bjørn-Erik, Viste, Kristin, Helland, Thomas, Hagland, Magnus, Søiland, Håvard, Geisler, Jürgen, Lende, Tone Hoel, Lønning, Per Eystein, Sagen, Jørn V, Mellgren, Gunnar, Almås, Bjørg
Izdano 2021Tekst -
7
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients od Helland, Thomas, Henne, Nina, Bifulco, Ersilia, Naume, Bjørn, Borgen, Elin, Kristensen, Vessela N., Kvaløy, Jan T., Lash, Timothy L., Alnæs, Grethe I. G., van Schaik, Ron H., Janssen, Emiel A. M., Hustad, Steinar, Lien, Ernst A., Mellgren, Gunnar, Søiland, Håvard
Izdano 2017Tekst -
8
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial od DeCensi, Andrea, Johansson, Harriet, Helland, Thomas, Puntoni, Matteo, Macis, Debora, Aristarco, Valentina, Caviglia, Silvia, Webber, Tania Buttiron, Briata, Irene Maria, D’Amico, Mauro, Serrano, Davide, Guerrieri-Gonzaga, Aliana, Bifulco, Ersilia, Hustad, Steinar, Søiland, Håvard, Boni, Luca, Bonanni, Bernardo, Mellgren, Gunnar
Izdano 2021Tekst -
9
Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen od Helland, Thomas, Naume, Bjørn, Hustad, Steinar, Bifulco, Ersilia, Kvaløy, Jan Terje, Sætersdal, Anna Barbro, Synnestvedt, Marit, Lende, Tone Hoel, Gilje, Bjørnar, Mjaaland, Ingvil, Weyde, Kjetil, Blix, Egil Støre, Wiedswang, Gro, Borgen, Elin, Hertz, Daniel Louis, Janssen, Emiel Adrianus Maria, Mellgren, Gunnar, Søiland, Håvard
Izdano 2020Tekst -
10
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Pro... od Søiland, Håvard, Janssen, Emiel A M, Helland, Thomas, Eliassen, Finn Magnus, Hagland, Magnus, Nordgård, Oddmund, Lunde, Siri, Lende, Tone Hoel, Sagen, Jørn Vegard, Tjensvoll, Kjersti, Gilje, Bjørnar, Jonsdottir, Kristin, Gudlaugsson, Einar, Lode, Kirsten, Hagen, Kari Britt, Gripsrud, Birgitta Haga, Lind, Ragna, Heie, Anette, Aas, Turid, Austdal, Marie, Egeland, Nina Gran, Bernklev, Tomm, Lash, Timothy L, Skartveit, Linn, Kroksveen, Ann Cathrine, Oltedal, Satu, Kvaløy, Jan Terje, Lien, Ernst A, Sleire, Linda, Mellgren, Gunnar
Izdano 2022Tekst